New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
15:34 EDTARNAArena Pharmaceuticals drops after CHMP issues recommendations
The stock is down over 5.4% at time of writing, edging toward session lows. At the current price of $9.87, next support is at $9.47. Resistance is at the 10-day moving average, last at $10.03.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
06:47 EDTARNAArena says Teva files marketing authorization of Belviq in Israel
Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.
06:45 EDTARNAArena says Eisai withdraws Belviq application in Canada
Subscribe for More Information
06:44 EDTARNAArena Pharmaceuticals says 'small number' of Belviq labels incomplete
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use